ArticleAntimicrobial agents and chemotherapy2016

Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility.

Ronald N Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.